Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?
Expert Rev Clin Immunol
.
2013 Dec;9(12):1155-7.
doi: 10.1586/1744666X.2013.858602.
Author
Anne S De Groot
1
Affiliation
1
EpiVax, Inc., 146 Clifford St, Providence, RI 02903, USA and University of Rhode Island, Institute for Immunology and Informatics, RI, USA +1 401 272 2123 +1 401 272 7562 dr.annie.degroot@gmail.com; annied@epivax.com.
PMID:
24215404
DOI:
10.1586/1744666X.2013.858602
No abstract available
Publication types
Editorial
MeSH terms
Animals
Autoimmune Diseases / immunology*
Autoimmune Diseases / therapy*
Humans
Immunodominant Epitopes / immunology*
Immunotherapy* / trends
T-Lymphocytes, Regulatory / immunology*
Substances
Immunodominant Epitopes